The Impact of Oxidative Stress on HIV-induced Lung Disease

氧化应激对 HIV 引起的肺病的影响

基本信息

  • 批准号:
    8638119
  • 负责人:
  • 金额:
    $ 53.54万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-09-26 至 2018-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Lung diseases are major causes of morbidity and mortality in patients infected with the Human Immunodeficiency Virus (HIV). Currently antiretroviral therapy (ART) has changed HIV into a chronic disease. In the pre-ART era, pulmonary infections were very common. In patients with ART, however, pulmonary infections are less frequent and noninfectious lung disorders, such as COPD, pulmonary hypertension, lung cancer, and pulmonary fibrosis are emerging as important causes of illness. These are important cause of morbidity and mortality, yet the mechanisms responsible for these disorders in HIV patients are unknown. All pulmonary disorders mentioned above are associated with, among other things, lung inflammation and tissue remodeling characterized by alterations in matrix expression, deposition, and degradation. Interestingly, HIV infection is also associated with oxidant stress caused by oxidation of the thiol disulfide couple cysteine (Cys)/cysteine (CySS) redox potential (Eh); also termed Eh Cys/CySS. This is important because in vitro studies show that an oxidized Eh Cys/CySS stimulates lung cells to produce more fibronectin (a matrix glycoprotein implicated in tissue injury and repair), transforming growth factor b (a pro-fibrotic growth factor), and pro-inflammatory cytokines like interleukin-1b. It also stimulates the proliferation and epithelial- mesenchymal transformation of lung fibroblasts, processes implicated in tissue remodeling. These data suggest that HIV-related oxidation of Eh Cys/CySS may promote lung tissue remodeling. We have shown that one mechanism by which oxidation of Eh Cys/CySS stimulates tissue remodeling is through the activation of nicotinic acetylcholine receptors (nAChRs). This is intriguing considering that HIV-1 proteins like gp120 bind and increase the expression and signaling of nAChRs expressed in brain, and this mechanism has been implicated in HIV-related dementia. We hypothesize that patients with HIV infection have oxidation of the Eh Cys/CySS which, together with gp120, activates nAChR-mediated signaling in lung cells and leads to their expression of cellular products with pro-inflammatory and pro-fibrotic effects such as cytokines and growth factors, matrix glycoproteins, and tissue proteases. The persistent and exaggerated production of these factors activates lung tissue remodeling thereby promoting HIV-related lung disease. The type of disease developed (e.g., COPD versus pulmonary hypertension), however, is dependent on both the genetic makeup of the subject and external factors such as smoking and infection. It is important that this hypothesis be tested considering that diet and other interventions have been shown to influence Eh Cys/CySS (9). If found to be causal, Eh Cys/CySS and nAChRs can be targeted for intervention in the hope of reducing the incidence and/or severity of HIV-related non-infectious lung disease.
描述(由申请人提供):肺部疾病是感染人类免疫缺陷病毒(HIV)患者发病率和死亡率的主要原因。目前,抗逆转录病毒疗法(ART)已将HIV改变为慢性疾病。在艺术前时代,肺部感染非常普遍。然而,在患有ART的患者中,肺部感染的频率较低和非感染性肺部疾病,例如COPD,肺部高血压,肺癌和肺纤维化是重要的疾病原因。这些是发病率和死亡率的重要原因,但是尚不清楚艾滋病毒患者这些疾病的机制。上面提到的所有肺部疾病都与肺部炎症和组织重塑有关,其特征是基质表达,沉积和降解的改变。有趣的是,HIV感染还与二硫基二硫基对半胱氨酸(CYS)/半胱氨酸(CYSS)氧化还原势(EH)氧化引起的氧化应激有关;也称为EH CYS/CYSS。这很重要,因为体外研究表明,氧化的EH Cys/Cyss刺激肺细胞产生更多的纤连蛋白(一种与组织损伤有关的基质糖蛋白),转化生长因子B(一种促纤维化生长因子)(一种促纤维化生长因子),以及诸如interleukin-1b之类的促炎细胞因子。它也刺激 肺成纤维细胞的增殖和上皮 - 间充质转化,与组织重塑有关的过程。这些数据表明,EH CYS/CYS的HIV相关氧化可能促进肺组织重塑。我们已经表明,EH Cys/Cyss氧化刺激组织重塑的一种机制是通过激活烟碱乙酰胆碱受体(NACHRS)。考虑到像GP120这样的HIV-1蛋白结合并增加了大脑中表达的NACHR的表达和信号传导,这很有趣,并且该机制与HIV相关痴呆症有关。我们假设HIV感染患者对EH Cys/Cyss的氧化作用,这些EH CYS/CYS与GP120一起激活NACHR介导的肺细胞中的NACHR介导的信号传导,并导致其具有促炎和纤维化的细胞产物,具有促纤维化和纤维化作用,例如细胞因子和生长因子,例如细胞因子和生长因子,Matrix glycopopotins and Tisture蛋白和组织蛋白质和组织蛋白质和组织蛋白质和组织蛋白质。这些因素的持续和夸大产生激活肺组织重塑,从而促进与HIV相关的肺部疾病。然而,开发的疾病类型(例如,COPD与肺高血压)取决于受试者的基因组成和外部因素,例如吸烟和感染。考虑到饮食和其他干预措施会影响EH CYS/CYSS(9),因此必须检验该假设。如果发现有因果关系,则可以将EH CYS/CYS和NACHRS用于干预,以期降低与HIV相关的非感染性肺部疾病的发病率和/或严重程度。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JESSE ROMAN其他文献

JESSE ROMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JESSE ROMAN', 18)}}的其他基金

Early life exposures and chronic lung disease
早期生活暴露和慢性肺病
  • 批准号:
    9887817
  • 财政年份:
    2020
  • 资助金额:
    $ 53.54万
  • 项目类别:
Early life exposures and chronic lung disease
早期生活暴露和慢性肺病
  • 批准号:
    10357796
  • 财政年份:
    2020
  • 资助金额:
    $ 53.54万
  • 项目类别:
Early life exposures and chronic lung disease
早期生活暴露和慢性肺病
  • 批准号:
    10579253
  • 财政年份:
    2020
  • 资助金额:
    $ 53.54万
  • 项目类别:
The Impact of Oxidative Stress on HIV-induced Lung Disease
氧化应激对 HIV 引起的肺病的影响
  • 批准号:
    9319801
  • 财政年份:
    2013
  • 资助金额:
    $ 53.54万
  • 项目类别:
The Impact of Oxidative Stress on HIV-induced Lung Disease
氧化应激对 HIV 引起的肺病的影响
  • 批准号:
    9116287
  • 财政年份:
    2013
  • 资助金额:
    $ 53.54万
  • 项目类别:
The Impact of Oxidative Stress on HIV-induced Lung Disease
氧化应激对 HIV 引起的肺病的影响
  • 批准号:
    8743254
  • 财政年份:
    2013
  • 资助金额:
    $ 53.54万
  • 项目类别:
The Impact of Oxidative Stress on HIV-induced Lung Disease
氧化应激对 HIV 引起的肺病的影响
  • 批准号:
    8898908
  • 财政年份:
    2013
  • 资助金额:
    $ 53.54万
  • 项目类别:
Receptor-mediated effects of ethanol in lung tissue injury and repair
乙醇在肺组织损伤和修复中的受体介导作用
  • 批准号:
    8236603
  • 财政年份:
    2012
  • 资助金额:
    $ 53.54万
  • 项目类别:
Receptor-mediated effects of ethanol in lung tissue injury and repair
乙醇在肺组织损伤和修复中的受体介导作用
  • 批准号:
    8530116
  • 财政年份:
    2012
  • 资助金额:
    $ 53.54万
  • 项目类别:
Receptor-mediated effects of ethanol in lung tissue injury and repair
乙醇在肺组织损伤和修复中的受体介导作用
  • 批准号:
    8668829
  • 财政年份:
    2012
  • 资助金额:
    $ 53.54万
  • 项目类别:

相似国自然基金

基于病证结合的冠心病心力衰竭血瘀证演变规律及中医药干预机制研究
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    297 万元
  • 项目类别:
    重点项目
基于动态关联网络分析策略的非创伤性股骨头坏死血瘀证病机演变规律及病证方结合研究
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    297 万元
  • 项目类别:
    重点项目
青海血蜱唾液腺内凝血因子FⅡa/FXa结合蛋白的筛选鉴定
  • 批准号:
    81760375
  • 批准年份:
    2017
  • 资助金额:
    33.0 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Contribution of Endothelial Planar Cell Polarity pathways in Blood Flow Direction Sensing
内皮平面细胞极性通路在血流方向传感中的贡献
  • 批准号:
    10750690
  • 财政年份:
    2024
  • 资助金额:
    $ 53.54万
  • 项目类别:
Molecular basis of glycan recognition by T and B cells
T 和 B 细胞识别聚糖的分子基础
  • 批准号:
    10549648
  • 财政年份:
    2023
  • 资助金额:
    $ 53.54万
  • 项目类别:
Endothelial Cell Reprogramming in Familial Intracranial Aneurysm
家族性颅内动脉瘤的内皮细胞重编程
  • 批准号:
    10595404
  • 财政年份:
    2023
  • 资助金额:
    $ 53.54万
  • 项目类别:
Molecular mechanisms regulating LMO2+ metastasis initiating cells
调节LMO2转移起始细胞的分子机制
  • 批准号:
    10659840
  • 财政年份:
    2023
  • 资助金额:
    $ 53.54万
  • 项目类别:
Cellular and Metabolic Dysfunction in Sepsis-Induced Immune Paralysis
脓毒症引起的免疫麻痹中的细胞和代谢功能障碍
  • 批准号:
    10724018
  • 财政年份:
    2023
  • 资助金额:
    $ 53.54万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了